Clinical Trial Update: Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal Allergic Rhinitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating TQH2722 injection with background therapy for seasonal allergic rhinitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• TQH2722 (TQH2722)

Snippet

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: RECRUITING